Loading...

Chimerix, Inc.

CMRX•NASDAQ
Healthcare
Biotechnology
$8.54
$0.00(0.00%)
U.S. Market is Open • 11:06

Chimerix, Inc. (CMRX) Stock Overview

Explore Chimerix, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap801.1M
P/E Ratio-8.67
EPS (TTM)$-0.99
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$7.96

CMRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chimerix, Inc. (CMRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $7.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.67 and a market capitalization of 801.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
65.83%
6-Month Change
834.66%
Year-to-Date (YTD) Change
151.92%
1-Year Change
775.90%
3-Year Change
263.40%
5-Year Change
153.41%
All-Time (Max) Change
-54.55%

Contact Information

https://www.chimerix.com
919 806 1074
2505 Meridian Parkway, Durham, NC, 27713

Company Facts

790 Employees
IPO DateApr 11, 2013
CountryUS

Frequently Asked Questions